MLYS · Mineralys Therapeutics, Inc. · Executive Compensation

$21.54 +0.07 (+0.33%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.90B

88.41M

Volume · Oct 22 824.73K Avg daily vol (3M) 1.13M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jon Congleton	President and Chief Executive Officer	$636,500	—	—	$4,435,626	$472,601	—	$5,544,727
David Rodman	Chief Medical Officer	$533,000	$25,000	—	$1,322,906	$323,798	—	$2,204,704
Adam Levy	Chief Financial Officer and Secretary	$532,000	$25,000	—	$1,322,906	$323,190	—	$2,203,096

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jon Congleton	President and Chief Executive Officer	$580,000	—	—	$4,537,818	$303,050	—	$5,420,868
David Rodman	Chief Medical Officer	$520,000	—	—	$2,135,449	$222,300	—	$2,877,749
Adam Levy	Chief Financial Officer and Secretary	$500,000	—	—	$2,135,450	$213,750	—	$2,849,200

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jon Congleton	President and Chief Executive Officer	$517,000	—	—	$4,579,482	$245,575	—	$5,342,057
David Rodman	Chief Medical Officer	$500,000	—	—	$1,620,457	$213,750	—	$2,334,207
Adam Levy	Chief Financial Officer and Secretary	$450,000	$21,375	—	$1,533,806	$171,000	—	$2,176,181

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jon Congleton	Chief Executive Officer	$416,667	$72,450	$1,118,118	—	$120,750	$12,200	$1,740,185
David Rodman	Chief Medical Officer	$411,458	$71,544	—	$492,064	$119,241	$12,200	$1,106,507
Adam Levy	Chief Financial Officer and Secretary	$334,926	—	$483,500	—	$190,900	$7,262	$1,016,588

Executive changes

Person	Role	Change	Effective	Filed
Lonnel Coats	Class II director	Appointed	2026-10-19	2026-10-19
Kristine Peterson	Class I director	Appointed	2026-10-19	2026-10-19
James J. Ferguson III, M.D.	Chief Medical Officer	Appointed	2026-08-10	2026-08-11
Olivier Litzka, Ph.D.	the Board	Resigned	2024-06-13	2024-06-14
Alexander M. Gold, M.D.	member of the Board and the Nominating and Corporate Governance Committee of the Board	Appointed	2024-06-13	2024-06-14
Minji Kim, Ph.D.	Chief Business Officer	Appointed	2024-01-04	2024-01-04
Glenn P. Sblendorio	Class II director	Appointed	2023-09-13	2023-09-14
Daphne Karydas	Class III director	Appointed	2023-09-13	2023-09-14
Takeshi Takahashi, M.B.A.	Board of Directors	Resigned	2023-09-12	2023-09-14

Leadership

Jon Congleton CEO, Board Member
Glenn P. Sblendorio Chairman
Alexander Gold Board Member
Alexander M. Gold, M.D. Board Member
Brian Taylor Slingsby Board Member
Daphne Karydas Board Member
Derek DiRocco Board Member
Kristine Peterson Board Member
Lonnel Coats Board Member
Srinivas Akkaraju Board Member

Key facts CIK 1933414 CUSIP 603170101 13F (30d) 17 filings 17 filers Visit website Investor relations